Agios Pharmaceuticals (AGIO) EPS (Weighted Average and Diluted): 2013-2025
Historic EPS (Weighted Average and Diluted) for Agios Pharmaceuticals (AGIO) over the last 6 years, with Sep 2025 value amounting to -$1.78.
- Agios Pharmaceuticals' EPS (Weighted Average and Diluted) fell 110.97% to -$1.78 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7, marking a year-over-year decrease of 161.62%. This contributed to the annual value of $11.64 for FY2024, which is 283.89% up from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) is -$1.78, which was up 7.77% from -$1.93 recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $26.95 during Q1 2021, and its lowest value of -$1.93 during Q2 2025.
- Over the past 3 years, Agios Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.64 (recorded in 2023), while the average stood at -$0.02.
- Per our database at Business Quant, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) spiked by 4,110.94% in 2021 and then tumbled by 356.72% in 2023.
- Agios Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.74 in 2021, then soared by 138.51% to $0.67 in 2022, then plummeted by 356.72% to -$1.72 in 2023, then declined by 1.16% to -$1.74 in 2024, then tumbled by 110.97% to -$1.78 in 2025.
- Its EPS (Weighted Average and Diluted) was -$1.78 in Q3 2025, compared to -$1.93 in Q2 2025 and -$1.55 in Q1 2025.